RNAC
Cartesian Therapeutics Inc.
7.10$
-3.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -151.1% | – | – | – | – | – | – | – | |
| – | +43.9% | -32.7% | +7.1% | +53.1% | +62.0% | +137.9% | -49.0% | +2.9% | +0.3% | +1.2% | +26.7% | – | |
| – | +649.6% | -91.8% | +11.2% | +6.5% | +10.0% | +34.5% | +30.7% | -21.0% | -17.2% | +13.0% | -14.0% | – | |
| – | – | – | – | – | -73.5% | -203.4% | – | – | -100.6% | – | +470.6% | – | |
| – | – | +840.6% | +163.6% | +290.6% | -88.6% | +52.5% | +141.4% | -50.2% | -61.9% | -94.5% | +907.4% | – | |
| – | – | -109.3% | +163.6% | +290.6% | -94.3% | +203.7% | +141.4% | -50.2% | -61.9% | -94.5% | +907.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +205.6% | -99.7% | +103,645.0% | -99.4% | -1,124.9% | – | -163.3% | +36.8% | – | +121.3% | – | |
| – | – | – | -160.0% | – | -105.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -202.9% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.